Source: Fortune
Summary
Terrell Davis, a two-time Super Bowl champion, has partnered with Teva Pharmaceuticals to raise awareness for Tardive Dyskinesia, a neurological movement disorder. Davis, who has publicly discussed his own mental health struggles, aims to encourage patients to discuss symptoms with healthcare providers. The campaign aligns with Teva’s commercial interests, as the company manufactures Austedo, a leading prescription treatment for Tardive Dyskinesia. Davis insists his involvement is driven by personal experience, having been prescribed medication for mental health treatment.
Our Reading
The numbers tell one story. Teva Pharmaceuticals invests in a marketing campaign featuring Terrell Davis, a trusted athlete, to raise awareness for Tardive Dyskinesia. The campaign directs patients to educational resources and encourages them to discuss symptoms with healthcare providers. Davis’s involvement is driven by personal experience, having been prescribed medication for mental health treatment. The campaign aligns with Teva’s commercial interests, as the company manufactures Austedo, a leading prescription treatment for Tardive Dyskinesia. “If I can get behind this and make TD synonymous with Tardive Dyskinesia,” Davis said, “I think that’s a pretty good thing.”
The strategy enters a familiar phase. Pharmaceutical companies are increasingly investing in marketing campaigns featuring trusted athletes to raise awareness for underdiagnosed conditions. The common thread is credibility, as athletes share deeply personal stories, making them more believable messengers. This credibility has become increasingly valuable for drugmakers trying to educate patients about underdiagnosed conditions.
Author: Evan Null
